The University of Maryland, Baltimore (UMB) is at the forefront of supporting the biomedical research industry in Baltimore.UMB and the University of Maryland Baltimore County (UMBC) were jointly awarded a four-year, $4 million Research Evaluation and Commercialization Hubs (REACH) grant from the National Institutes of Health (NIH) to advance the biomedical entrepreneurship and innovation economy in the Baltimore region.This grant will be used to build on the work that began when UMBC and the University of Maryland School of Medicine (UMSOM) received a $13 million NIH Common Fund Faculty Institutional Recruitment for Sustainable Transformation (FIRST) grant in 2022 to enhance recruitment and training of junior faculty from groups underrepresented in biomedical science.UMB will also use the grant to create the University of Maryland, Baltimore Life Science Discovery (UM-BILD) Accelerator program’s “proof-of-concept” hub — one of only five NIH-funded proof-of-concept hubs in the U.S. — in the University of Maryland BioPark and at bwtech@UMBC.Jim Hughes, chief enterprise and economic development officer and senior vice president for UMB, spoke to the Baltimore Mayor and City Council recently about the impact of the grant.
More from Youtube
- 0:45Can a Weight-Loss Drug Help Treat Cocaine Addiction? | Breakthroughs Can’t WaitCan a weight-loss drug help treat cocaine addiction?At the University of Maryland, Baltimore, researchers are exploring how GLP-1 receptor agonists — a class of drugs commonly used for weight loss — may offer new hope for people with cocaine use disorder. This is just one example of how federally funded research at UMB is Changing The Future Today.Hear from Sarah Kattakuzhy, MD, co-director for the Research Initiative on Infectious Disease and Substance Use Disorder, at the University of Maryland School of Medicine explains. Kattakuzhy is also the associate director of the Kahlert Institute for Addiction Medicine.🧪 Breakthroughs Can’t Wait: UMB research drives innovation, improves lives, and tackles global challenges. But we can’t do it without continued support.🔗 Learn more and support research that saves lives: https://www.umaryland.edu/breakthroughs #BreakthroughsCantWait #NIHfunding #CocaineUseDisorder #GLP1 #AddictionResearch #UMB #ResearchMatters
- 4:53Changing the Future of Addiction Care | Breakthroughs Can’t Wait with Dr. Sarah KattakuzhyCan a class of drugs best known for treating diabetes and weight loss also help people struggling with cocaine use disorder?Dr. Sarah Kattakuzhy, an associate professor at the University of Maryland School of Medicine, is leading innovative research on GLP-1 receptor agonists — medications that may offer a new path forward in treating addiction.This NIH-funded research could transform how we understand and address substance use, giving people more options — and more hope.🧪 Breakthroughs Can’t Wait: UMB research drives innovation, improves lives, and tackles global challenges. But we can’t do it without continued support.🔗 Learn more and support research that saves lives: https://www.umaryland.edu/breakthroughs#BreakthroughsCantWait #AddictionResearch #CocaineUseDisorder #GLP1 #SubstanceUseDisorder #UMBResearch #NIHfunding #HealthInnovation #DrSarahKattakuzhy
- 4:24UMB's 13th Annual Interprofessional Education DayHosted by the University of Maryland Baltimore's Center for Interprofessional Education (CIPE) on April 2, IPE Day brought together more than 170 students from all seven UMB professional schools — including medicine, nursing, pharmacy, law, dentistry, physical therapy, social work, and the Graduate School — for a full afternoon of collaborative learning, simulation activities, and real-life insights into the power of team-based care.Read more: https://www.umaryland.edu/news/archived-news/april-2025/ipe-day-centers-on-listening-to-patients-and-peers.php
- 59:34Virtual Face to Face: The Challenges Facing Academic ResearchThe changes and challenges facing academic research and the University of Maryland, Baltimore's response was the topic of Virtual Face to Face on April 10 hosted by James Hughes, MBA, Chief Enterprise and Economic Development Officer and Senior Vice President. Hughes was joined by University of Maryland School of Medicine Professor and Executive Vice Dean Chris O’Donnell, PhD, and E. Albert Reece, MD, PhD, MBA, Director of the Center for Advanced Research Training and Innovation.
- 1:01:46Legal Challenges in Higher EducationOn April 1, the legal challenges facing higher education were the subjects of discussion on Virtual Face to Face. Program host and University of Maryland, Baltimore President Bruce E. Jarrell, MD, FACS, spoke with University of Maryland Francis King Carey Dean and Professor Renée; Carey Law Professor Marley Weiss, JD; and Carey Law Assistant Professor Chris Mathis, JD. The program included questions from an audience of 500 UMB faculty, staff, and students.
- 3:42Open Works Collaboration with University of Maryland, BaltimoreThe University of Maryland, Baltimore (UMB) Office of Community and Civic Engagement (OCCE) has launched a new partnership with Open Works, one of the nation’s largest nonprofit makerspaces, to expand access to hands-on maker education in West Baltimore.As part of this collaboration, Open Works is now serving as an operating partner of the Steve and Mim Dubin Makerspace at UMB’s Community Engagement Center (CEC) to support creative learning and technical skill-building in the Poppleton neighborhood.Together, UMB and Open Works aim to deliver exceptional programming and broaden access to fabrication, digital design, and technologies — including tools like the Glowforge laser cutter — all while working side-by-side with neighbors to ensure offerings are relevant and responsive to community needs.
